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The early postnatal period is a critical window for intestinal and immune maturation. Intestinal
development and microbiome diversity and composition differ between breast- (BF) and formula-
fed (FF) infants. Mechanistic examination into host–microbe relationships in healthy infants has
been hindered by ethical constraints surrounding tissue biopsies. Thus, a statistically rigorous ana-
lytical framework to simultaneously examine both host and microbial responses to dietary/environ-
mental factors using exfoliated intestinal epithelial cells was developed. Differential expression of
1200 genes, including genes regulating intestinal proliferation, differentiation and barrier func-
tion, was observed between BF and FF term infants. Canonical correlation analysis uncovered a rela-
tionship between microbiome virulence genes and host immunity and defense genes. Lastly,
exfoliated cells from preterm and term infants were compared. Pathways associated with immune
cell function and inﬂammation were up-regulated in preterm, whereas cell growth-related genes
were up-regulated in the term infants. Thus, coordinate measurement of the transcriptomes of exfo-
liated epithelial cells and microbiome allows inquiry into mutualistic host–microbe interactions in
the infant, which can be used to prospectively study gut development or, retrospectively, to identify
potential triggers of disease in banked samples.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Intestinal epithelial cells and the commensal microbiota are in
close and intimate contact. Studies emanating from germ free
and gnotobiotic animals have provided conclusive evidence of
the critical role of the intestinal microbiota in regulating gut devel-
opment and gene expression [1,2], mucosal and systemic immu-
nity [3], the enteric nervous system [4], gut brain axis [5] and
host metabolism [6,7]. Recent studies have dispelled the conceptthat amniotic ﬂuid and meconium are sterile under normal condi-
tions [8]. Meconium, which is formed primarily by ingestion of
amniotic ﬂuid by the fetus in utero, also contains exfoliated intes-
tinal cells and mucus. The meconium microbiome is inﬂuenced by
maternal factors, including clinical conditions [9] and probiotic use
[10], and may impact child health outcomes [8,9,11]. Thus, host–
microbe interactions and education of the neonatal immune sys-
tem begin in the womb [8].
Immediately after delivery, the human infant acquires a much
more complex microbiota, whose composition is inﬂuenced by
an interplay between genetic and environmental factors [12], of
which nutrition is a key component [13]. At the same time, the gas-
trointestinal tract undergoes rapid structural and functional adap-
tation, which differs between breast-fed (BF) and formula-fed (FF)
infants [14,15]. Although human milk contains growth factors and
bioactive proteins and lipids that may directly promote the growth
of the gastrointestinal tract [16,17], we speculated that dissimilar-
ities in the composition of the microbiota between breast- and
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enhanced gut development observed by mode of nutrition [14,15].
Our long-term goal is to determine the role of host–microbe
interactions within the neonatal intestine on infant development
and to deﬁne how these cross-functional communications are
affected by diet. Among the components of human milk that shape
the composition of the microbiota are the humanmilk oligosaccha-
rides (HMO). The HMO are comprised of a mixture of up to 200
complex oligosaccharides that constitute the third most predomi-
nant component of human milk [19]. The HMO content and com-
position is inﬂuenced by the mothers’ genetics (FUT-2 secretor
status and Lewis blood group) [20], preterm delivery [21] and, to
a lesser degree, the stage of lactation, where sialic acid containing
HMO decline, while fucosylated HMO increase or stay constant
over the course of lactation [19]. The potential physiological roles
of HMO for the developing infant is far reaching in that their mul-
tifunctional actions range from regulation of intestinal cell prolifer-
ation, functional differentiation and apoptosis [22,23], gene
expression [24], immune function [25–27], pathogen protection
[28,29], and prebiotic activities, including serving as substrates
for fermentation [30,31] and promoting growth of speciﬁc biﬁdo-
bacteria [32], bacteroides [33] and Lactobacillus [34] species
(reviewed in [35]).
We hypothesize that nutrition is a central regulator of host–
microbe interactions in early life. As noted above, the composition
of the microbiota of BF and FF infants differs in terms of overall
diversity as well as composition [12,13,18]. Epidemiological stud-
ies have demonstrated that human milk protects against common
infectious diseases in infancy (otitis media, respiratory syncytial
virus, urinary tract infection), necrotizing enterocolitis (NEC) in
preterm infants as well as immune-mediated disorders in later
childhood, including allergy, asthma, atopic dermatitis, inﬂamma-
tory bowel disease, Celiac Disease, Type 1 and Type 2 diabetes mel-
litus, and leukemia (ALL and AML) [36]. Recently, Walker [37]
proposed that a diverse balanced microbiota is necessary for the
development of an appropriate innate and adaptive immune
response. This is further supported by studies associating dysbiosis
in early life with immune-mediated childhood disorders [38–40]
and obesity [41,42]. Dysbioses can arise from common pediatric
practices, including preterm delivery, formula feeding, cesarean
section, and use of antibiotics [42,43] (Fig. 1). Interestingly, cesar-
ean section [43] and antibiotic use [44] are independently associ-
ated with an increased susceptibility to immune-mediated
disease, potentially through dysregulation of host immuneRoute of Delivery
Preterm Delivery
Fig. 1. Common pediatric practices that impact guhomeostasis [44,45]. It is important to note that all of these prac-
tices are amenable to changes in clinical protocols, and, as such,
should be a priority for pediatric practice.
Given the evidence that early life nutritional exposures program
long-term health outcomes, potentially through host–microbe
interactions, our research group set out to systematically integrate
genomic data from both the infant (host mucosa) and gut microbi-
ota in order to deﬁne host gene–diet interactions within the con-
text of the structure and operations of gut microbial
communities. Until recently, no investigators had comprehensively
proﬁled intestinal gene expression during early postnatal develop-
ment due to limited availability of intestinal tissue from healthy
infants. Thus, the potential for exfoliated epithelial cells to provide
a non-invasive readout of intestinal gene expression was investi-
gated [46–48].
2. Use of exfoliated cells to assess host gene expression
Each day, 1/3rd to 1/6th of normal adult epithelial cells are
shed [49], which corresponds to 10 billion (1010) cells per day.
Exfoliation of intestinal epithelial cells from the villus tips in the
small intestine and crypt surface in the colon is ab active biochem-
ical process linked to intestinal epithelial homeostasis [50]. Exfoli-
ation typically induces anoikis, rather than apoptosis, which is a
form of programmed cell death induced by anchorage-dependent
cells detaching from the surrounding extracellular matrix. Detach-
ment also induces autophagy, which is a survival mechanism to
loss of nutrients [51]. The exfoliated cells enter into a quiescent
state and appear to maintain viability for differing lengths of time
depending on the sources of cells. For example, quiescent exfoli-
ated epithelial cells without signs of apoptosis were recovered in
gastric ﬂuid aspirates obtained from preterm infants [52]. Further-
more, exfoliated quiescent epithelial cells can be cultured, evi-
denced by the ability to use exfoliated cells to forms lumens in
3-dimensional epithelial cell culture [47,48], suggesting that
detachment-induced autophagy contributes to the viability of
these cells.
This vast reservoir of host cells generated by exfoliation sparked
interest from both basic and clinical translational investigators due
to their potential utility to non-invasively assess cellular markers
of gastrointestinal disease, predominantly colon cancer [53,54].
Subsequently, exfoliated epithelial cells had been used as sentinels
of in vivo exposure to nutritional regimens [55,56] or as markers of
disease states, including cancer in adults [57,58] and children withBreast vs 
Formula 
Feeding
Antibiotics
t microbiota and host–microbe interactions.
Table 1
Studies in pediatric populations using exfoliated epithelial cells to measure the impact of diet, gestational age or probiotic administration on gene expression.
Author Population studied Tissue How obtained Key ﬁndings
Chapkin et al. [46] BF (n = 12) and FF (n = 10) term Intestine Stool 1214 Genes were differentially expressed
between BF and FF. Major gene pathways were
related to signal transduction, cytoskeletal
remodeling, cell adhesion and immune response
Kaeffer et al. [52] Preterm (n = 96); 24–36 wk GA Stomach;
intestine
Gastric aspirates;
stool
Exfoliated cells isolated from gastric aspirates
expressed housekeeping, cytokeratin, SLC-26-A7-
I, period 2 and clock genes by PCR
Kaeffer et al. [60] Preterm (n = 24); 25–32 wk GA Stomach Gastric aspirates;
collected weekly after
birth or every 3 h over
a 24 h period
H+/K+-ATPase positive cells expressing markers of
progenitor status were recovered from gastric
ﬂuid; aspirates in preterm infants. Exfoliation
increased with postnatal/post-conceptual age and
volume of enteral feeds and was greater in infants
fed preterm formula than preterm human milk
Knight et al. [48] Term (n = 6) and preterm (n = 6) Intestine Stool RNAseq analysis of host mRNA in stool. Pathways
associated with immune cell function and
inﬂammation were up-regulated in preterm
infants; cell growth related genes were up-
regulated in term infants
Rautava et al. [10] Term infants delivered by cesarean section
(n = 29). Mothers were given placebo (n = 10), 109
CFU Biﬁdobacterium lactis (n = 10) or 109 CFU B.
lactis + 109 CFU Lactobacillus rhamnosus GG (=9)
for 14 d prior to cesarean
Intestine Meconium PCR of host mRNA in meconium. Reduced TLR7
mRNA expression was detected in intestinal cells
from meconium of infants whose mothers
received B. lactis, while maternal B.
lactis + Lactobacillus GG decreased TLR6 mRNA
expression in fetal intestinal cells frommeconium
Schwartz et al. [47] BF (n = 6) and FF (n = 6) term Intestine Stool Virulence genes in the bacterial metagenome
were correlated with immunity and defense
genes in host exfoliated epithelial cells
Abbreviations: BF, breastfed; FF, CFU, colony forming units; formula-fed; GA, gestational age; PCR, polymerase chain reaction; TLR, toll like receptor.
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identifying protein markers and amplifying genes by polymerase
chain reaction was demonstrated in exfoliated gastric cells from
preterm infants [52,60]. Kaeffer and colleagues studied isolated
exfoliated cells obtained from gastric aspirates [52,60] and stool
samples [52] obtained from preterm infants. The gastric exfoliated
cells were conﬁrmed to be of epithelial origin by cytokeratin 18
expression and mRNA for beta-actin, clock genes and SLC26-A7-
1, an apical Cl/HCO3/sulfate exchanger present on parietal cells,
was detected [52]. They subsequently reported that exfoliated epi-
thelial cells isolated from gastric aspirates were quiescent and
expressed membrane bound H+/K+ ATPase. Importantly, when
the H+/K+ ATPase-positive cells were established in cell culture,
Pouf5F1-Oct4 expression, a biomarker of progenitor status, was
maintained [52].
Our goal was to investigate genome-wide markers by interro-
gating the transcriptome through gene microarray [46] or, more
recently, RNAseq [48]. Because the number of intact cells that
can be isolated from fecal material is low [53], the Chapkin labora-
tory developed a noninvasive mRNA-based method as a highly sen-
sitive technique for detecting molecular markers of intestinal
development and function [57,58]. This methodology has the
advantage of using host exfoliated cell mRNA directly isolated from
feces, which contain sloughed small intestinal and colon cells. The
method is capable of isolating and quantifying speciﬁc mRNAs
under various intestinal conditions and has been tested in adult
humans [58,61]. A summary of the studies that have applied exfo-
liated epithelial cells in pediatric populations is shown in Table 1
and will be discussed below.
3. Stool-derived eukaryotic mRNA can be used to non-invasively
assess the impact of nutrition on intestinal gene expression in
term infants
In a proof-of-principle study, stool samples containing exfoli-
ated host cells and luminal bacteria were collected from 3-
month-old exclusively BF or FF infants [46]. A total of 1214 genes
were signiﬁcantly differentially-expressed between BF and FFinfants, however, we focused our analyses on the 146 genes that
were included in a list of 529 genes that we had a priori hypothe-
sized could be differentially expressed based on prior knowledge.
Analysis of gene networks reﬂected broad differences with respect
to Signal Transduction (WNT, NOTCH, TGF-b), Cytoskeletal Remodel-
ing; Cell Adhesion and Immune Response [46]. Linear Discriminant
Analysis (LDA) was used to identify genes that best ‘‘classiﬁed’’
or discriminated BF from FF infants and the top up- and down-reg-
ulated genes and their fold-changes are shown Table 2. Although
these human milk-regulated genes were identiﬁed in term infants,
they could have particular importance to infants with impaired gut
development and function, including preterm infants. These genes
included glucocorticoid receptor (NRC31), as glucocorticoids are
key contributors to gut maturation, Z01 (TJP1) a critical tight junc-
tion protein, and a number of genes encoding proteins involved in
cell–cell interactions, including integrins, cadherins and syntaxin,
and proteins involved in cell proliferation and apoptosis [46]. Inter-
estingly, the most highly ranked gene for identifying BF versus FF
infants was Endothelial PAS domain-containing protein 1 (EPAS-
1; also known as Hypoxia-inducible factor-2a [HIF-2a]). It is well
known that human milk protects preterm infants from the devel-
opment of NEC, one of the most common causes of morbidity
and mortality in very low birth weight infants [62,63]. We postu-
late that induction of this gene may provide a mechanism whereby
the intestines of premature infants fed human milk are better able
to tolerate episodes of hypoxia and are thereby less likely to
develop NEC. In addition to being the best single classiﬁer, EPAS-
1 was an even stronger predictor when combined with other genes
in ten separate 2- or 3-gene combinations (an example is shown in
Fig. 2), thus providing potential biomarkers for nutritional modula-
tion of gut development [46].
4. Stool-derived eukaryotic mRNA and intestinal microbiota
DNA can be used to non-invasively evaluate host–microbe
interactions in the intestine of term infants
In an extension of this work, we created a novel methodology
designed to assess the multivariate relationship between the
Table 2
Early nutrition differentially regulates epithelial gene expression. Listed are the most highly up- and down-regulated genes in breastfed (BF) versus formula-fed (FF) infants.
Gene symbol and name Function of encoded gene Fold change (BF/FF)
Up-regulated in BF compared to FF
NR3C1; glucocorticoid receptor Transcription factor that binds to glucocorticoid response elements in the
promoters of glucocorticoid responsive genes
5.5
BAD; BCL-2-associated agonist of
apoptosis
Protein positively regulates cell apoptosis by forming heterodimers with
BCL-xL and BCL-2, and reversing their death repressor activity
4.0
PCDH7; protocadherin Gene product is an integral membrane protein that is thought to function in
cell–cell recognition and adhesion
3.9
EPAS1; endothelial PAS domain
protein 1
Transcription factor involved in the induction of genes regulated by oxygen,
which is induced as oxygen levels fall
3.3
NR5A2; nuclear receptor subfamily 5,
group A, member 2 or liver
receptor homolog-1 (LRH-1)
LRH-1 is important for maintaining pluripotence of stem cells during
embryonic development
2.8
MYB; v-myb avian myeloblastosis
viral oncogene homolog
Plays an important role in the control of proliferation and differentiation 2.8
Stx2; Syntaxin-2 Gene product regulates epithelial–mesenchymal interactions and epithelial
cell morphogenesis and activation
2.5
ITGB2; integrin beta-2 (CD18) ICAM Receptor; gene product is known to participate in cell adhesion as
well as cell-surface mediated signaling
2.5
TJP1; ZO-1 The N-terminal may be involved in transducing a signal required for tight
junction assembly, while the C-terminal may have speciﬁc properties of
tight junctions
2.2
Down-regulated in BF compared to FF
FOXE3 Forkhead box protein E3; cell proliferation 0.32
EGFR EGF Receptor; cell proliferation and migration 0.33
WNT7B Wingless-type MMRV integration site family, 7B; cell fate and cell
patterning
0.58
LYZL6 Lysozyme-like 6; bacteriostatic factor 0.70
HIF3A Hypoxia-inducible factor 3 alpha; negative regulator of hypoxia inducible
gene expression
0.71
DAPK1 Death-associated protein kinase 1; induction of apoptosis 0.73
APC Adenomatous polyposis coli; tumor suppressor 0.77
TDGF1 Teratocarcinoma-derived growth factor 3; cell growth 0.80
SPARC Secreted-protein, acidic, cysteine-rich (osteonectin); cell proliferation 0.82
From: Chapkin et al. [40].
Formula-fed
Breastfed
Fig. 2. Identiﬁcation of three-feature combination gene sets for diet. A strong
multivariate (three gene) discriminator of breast-fed (circles) versus formula-fed
(triangles) subjects is shown. Note that there is a clear separation between the two
groups, except for one outlier. SYP, synaptophysin; FOXE3, forkhead box protein E3;
EPAS1, endothelial PAS domain-containing protein 1 (hypoxia-inducible factor 2a).
From: Chapkin et al., 2010 [40].
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scriptome [47] as shown in Fig. 3. By examining the multivariate
structure underlying the bacterial metagenome or metatranscrip-
tome and gut exfoliated cell transcriptome, our approach leverages
richer and fuller information content compared to analyses focus-
ing on single data sets (e.g., only host transcriptome data or only
bacterial metatranscriptome data) and only single variables (e.g.,
gene by gene differential expression testing). We propose that this
‘‘integrative’’ strategy will help identify intestinal genes that are
responsive to diet and inﬂuenced by factors known to causedysbiosis in term and preterm infants (e.g. route of delivery, anti-
biotic use, formula feeding, parenteral nutrition).
Using this approach, phyla-level differences in the microbiota of
BF and FF infants were observed [47]. Microbiota functional charac-
teristics were mapped to functional SEED categories. Because of the
hierarchical structure of the SEED classiﬁcation system, aggregating
reads into coarser classiﬁcations provided for a more informed
analysis. Virulencewas the one SEED category that differed between
the bacterial metagenome of BF and FF infants [47]. To examine the
intrinsic relationship between host and microbiome, host tran-
scriptome and metagenomic data were combined and integrated
using the multivariate technique of canonical correlation analysis
(CCA) [47]. We examined whether a relationship existed between
microbiota virulence genes and sets of host immunity and defense
genes (n = 660), intestinal biology genes (n = 660) or a random
genes (n = 459). A robust multivariate structure relating microbiota
virulence genes and host immunity and defense geneswas observed.
Seven of the top eleven immunity and defense host genes that were
related to the microbiota were down-regulated in BF versus FF
infants, including ALOX5, a lipoxygenase involved in arachidonic
acid and leukotriene synthesis, the cytokine IL1a, and binding pro-
teins for natural killer cells (KLRF1), T-lymphocytes (AOC3) and LPS
(BPILI) [47]. These ﬁndings indicate that the overall impact of
breastfeeding was to reduce inﬂammatory genes in the gut poten-
tially promoting tolerance to the luminal microbes.
5. Stool-derived eukaryotic mRNA can be used to non-invasively
assess the impact of preterm delivery on intestinal gene
expression
We next applied our exfoliated cell transcriptomic approach to
the preterm infant [48]. Preterm birth, which affected 15 million
Impact of environmental factors on temporal 
changes in microbiota, metatranscriptome, host 
epithelial cell transcriptome and their interactions
Fig. 3. Experimental pipeline for simultaneous analysis of the host transcriptome and bacterial microbiome and metatranscriptome.
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is the second leading cause of death in children under 5 years
[64,65]. Infants born at <32 weeks gestational age (GA) are faced
with an unique set of challenges due to their developmental imma-
turity. In the U.S., the costs associated with preterm birth were
more than $26.2 billion in 2005 [66]. Emerging evidence has
clearly demonstrated direct and interactive links between diet,
the intestinal microbiome and immune development [67,68].
Many common diseases afﬂicting preterm infants are associated
with dysregulated immune function [69–73].
To determine whether sufﬁcient exfoliated epithelial cells could
be isolated from preterm infants and whether they would inform
developmental differences, host transcript abundance in healthy
full term (>38 weeks GA) and extremely preterm (24–30 weeks
GA) infants were measured using RNA-Seq [48]. Approximately,
5500 genes were detected (FPKM > 1) on average in both preterm
and term samples. Several key observations were made. First, geneexpression in preterm infants was more heterogeneous amongst
themselves and compared to term infants. Second, exfoliated cells
express genes associated with speciﬁc intestinal cell types includ-
ing absorptive enterocytes (lactase and sucrose–isomaltase), Gob-
let cells (mucin-2), enteroendocrine cells (chromogranin A), and
Paneth cells (lysozyme). Lastly, the transcriptional landscape is
dramatically altered in the preterm versus term infant intestine
[48].
Gene pathways that were over-expressed in preterm versus
term or term versus preterm intestine were evaluated. Although
none of the infants were clinically ill at the time the stool samples
were collected, preterm over-expressed genes related to immune
function. Several cytokines, including IL-1a and IL-33 were up-reg-
ulated in preterm versus term. In addition, several genes that reg-
ulate the expression of cytokines and other immune genes were
expressed at 3- (NFKB1a) to 6-fold (CASP1) higher levels in pre-
term versus term infant exfoliated cells [48]. This is consistent with
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ized cells isolated from fetuses (H4 cells) or tissue explants from
fetuses mount a more robust proinﬂammatory cytokine response
(IL-8) after inﬂammatory stimulation with lipopolysaccharide or
IL-1b than cells from adult tissue (Caco-2) or explants from older
children [74]. The excessive inﬂammatory response of the imma-
ture intestine appeared to be in part due to a developmental
under-expression of IkB [75] coupled with overexpression of the
NFkB/MyD88 innate inﬂammatory genes (TLR2, TLR4, MyD88,
TRAF-6, NFkB1 and IL-8) and reduced expression of negative regu-
lator genes (SIGIRR, IRAK-M, A-20 and TOLLIP) in fetal intestine rel-
ative to other children [75]. Thus, it appears that immaturity of the
intestinal innate immune response may contribute to excessive
inﬂammation in the intestine in response to colonizing bacteria,
which is a hallmark of NEC [76].
In contrast, in term infants, up-regulated immune genes were
involved in balancing the immune system, e.g., promoting T-cell
development (LCP2; 3.6-fold greater than preterm), while inhibit-
ing macrophage activation (LENG9; 16-fold greater than preterm).
The majority of genes were involved in cell turnover, by regulating
proliferation and apoptosis. One of the most highly differentially-
expressed genes was an anti-apoptotic factor (MTRNR2L6; 5-fold
higher in term than preterm). Another interesting gene was SP3
(2-fold higher in term than preterm), which is a transcription fac-
tor that can be regulated through short-chain fatty acid induced
acetylation [77,78], potentially supporting the role of products of
microbial metabolism in regulating normal gut growth in term
infants.
The underlying reason for differences in intestinal gene expres-
sion between preterm and term infants is multifactorial and may
be a result of the developmental immaturity of the preterm gut,
coupled with speciﬁc environmental exposures that are unique
to the post-natal course of this population. Although well-con-
trolled studies are needed to evaluate these exposures, this study
highlights the potential of using the described noninvasive tech-
nology. We anticipate that this approach will allow investigators
to elucidate how diet and bedside clinical management of this
immature population inﬂuences intestinal development and
immune ontogeny over time and has the potential for generating
comprehensive, diagnostic gene sets for the noninvasive identiﬁca-
tion/prediction of different intestinal phenotypes in infants.
In addition to the host gene networks that are affected by the
developing microbiota, the metabolic products from both microbes
and host can give rise to signaling and inﬂammatory pathways that
can affect numerous organs such as the lung, liver and brain in
addition to the intestinal tract [73]. Undoubtedly, the comprehen-
sive analysis of microbiota, intestinal transcriptome and metabo-
lites will provide an overall picture of the milieu that is
associated with many of the major morbidities seen in preterm
infants.
6. Eukaryotic mRNA-derived for meconium can be used to non-
invasively assess the impact of maternal probiotic treatment on
fetal intestinal immune gene expression in utero
The long-held belief that the fetus existed in a sterile intrauter-
ine environment and that introduction of bacteria into the amni-
otic ﬂuid would lead to an adverse pregnancy outcome has been
challenged by recent studies showing that the placenta, amniotic
ﬂuid and fetus contain a diversity bacteria and that these differ
between term and preterm infants [79,80]. Although dysbiosis
may trigger preterm delivery [11,81], other studies have described
a relatively complex placenta microbiota comprised of nonpatho-
genic commensal microbiota from the Firmicutes, Tenericutes, Pro-
teobacteria, Bacteroidetes, and Fusobacteria phyla [9,79,80] that,surprisingly, clusters more similarly to the maternal oral than vag-
inal or gut microbiota [79,82]. These results suggest that the pla-
cental and intrauterine bacteria do not ascend from the vagina,
but may be delivered through the circulation [82]. Rautava [10]
administered probiotics in order to investigate whether microbes
in placenta or amniotic ﬂuid affected fetal innate immune gene
expression during late pregnancy and whether innate immune
gene expression proﬁles in the placenta and the fetal gut may be
modulated by dietary supplementation with speciﬁc probiotics.
In a double-blind clinical trial, pregnant women were administered
either placebo, Biﬁdobacterium lactis (B. lactis) or B. lactis and Lacto-
bacillus rhamnosus GG (LGG) for 14 days before elective cesarean
section at full term [10]. Bacterial DNA was detected in all placenta
samples by PCR. Meconium samples were collected and host
mRNA extracted from fetal exfoliated epithelial cells using the
method of Chapkin and colleagues [46]. An association between
the presence of microbial DNA in amniotic ﬂuid and placenta and
changes in toll like receptor (TLR)-related gene expression in the
fetal intestine was observed. Additionally maternal probiotic sup-
plementation signiﬁcantly modulated the expression of TLR-
related genes both in the placenta and in the fetal gut. Compared
to mRNA expression in exfoliated cells of infants exposed to the
placebo, TLR6 mRNA expression was down-regulated nearly 90%
in exfoliated cells from infants whose mothers consumed B. lac-
tis + LGG, whereas TLR7 was down-regulated 70% in infants of
mothers administered B. lactis alone [10]. TLR are important medi-
ators of innate immunity through their recognition of highly con-
served microbial-associated molecular patterns. Speciﬁcally, TLR6
interacts with TLR2 to mediate cellular response to bacterial lipo-
proteins. TLR7 recognizes single-stranded RNA in endosomes,
which is a common feature of viral genomes [83]. These ﬁndings
support the hypothesis that microbial programming begins in fetal
life through host–microbe interactions in utero [8], which can be
manipulated by maternal probiotic intervention [10].
7. Summary
We have recently validated a novel molecular methodology that
utilizes stool samples containing intact sloughed epithelial cells to
noninvasively quantify intestinal gene expression proﬁles in the
developing human neonate, which is ‘‘an important ﬁrst step
towards a more comprehensive understanding of the biological
mechanisms underlying the parallel development of the host and
microbiome in early life’’ [84]. This approach enables repeated
assessment of the same infant overtime to assess temporal changes
in gene expression [40]. Furthermore, we have expanded upon this
methodology by combining host gene expression with the bacte-
rial metagenome from the same infant [47]. This approach is statis-
tically rigorous and is sensitive to dietary intake [46,47] and the
stage of gestation [48]. In conclusion, we propose that the investi-
gation of host–microbiome interaction will ﬁll an important gap in
our understanding of the coordinated development of gut microbi-
ota and the infant intestine. In the long-term, it is anticipated that
nutritional strategies to improve the development of the microbi-
ome and intestine will enhance the clinical care of high-risk
infants.
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